Editorial: Safety and Tolerability of Psychotropic Compounds
- PMID: 32625046
- PMCID: PMC7314897
- DOI: 10.3389/fnins.2020.00509
Editorial: Safety and Tolerability of Psychotropic Compounds
Keywords: anticholinegic; antipsychotic; hyperprolactinemia; psychotropic adverse effects; safety; tardive dykinesia; tolerability.
Comment on
- Editorial on the Research Topic Safety and Tolerability of Psychotropic Compounds
References
-
- Higashi K., Medic G., Littlewood K. J., Diez T., Granström O., De Hert M. (2013). Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Therap. Adv. Psychopharmacol. 3, 200–218. 10.1177/2045125312474019 - DOI - PMC - PubMed
-
- Montejo A. L., Arango C., Bernardo M., Carrasco J. L., Crespo-Facorro B., Cruz J. J., et al. . (2017). Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics. Front. Neuroendocrinol. 45:3. 10.1016/j.yfrne.2017.02.003 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources